Qiagen NV - Company Profile

Powered by

All the sales intelligence you need on Qiagen NV in one solution.

$395 $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Qiagen NV fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Qiagen NV.

Back to companies

Qiagen NV: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Related keylists

Qiagen NV (Qiagen) is a provider of molecular testing solutions. The company’s sample technologies help isolate and process DNA, RNA, and proteins from samples such as blood, tissue and other materials. It develops assay technologies to identify the genetic information of a pathogen in a tumor; bioinformatics solutions to analyze and interpret genomic data; and solutions to automate the use of consumables into efficient molecular testing workflows. It serves human healthcare, forensics, veterinary diagnostics, food safety testing, pharmaceutical and biotechnology and life sciences research markets. The company offers products directly and through a network of independent distributors. It has operations in the Americas, Europe, the Middle East, Africa, and Asia-Pacific. Qiagen is headquartered in Venlo, the Netherlands.

 Gain a 360-degree view of Qiagen NV and make more informed decisions for your business Gain a 360-degree view of Qiagen NV and make more informed decisions for your business Learn more
Headquarters Netherlands
Address Hulsterweg 82, Venlo, 5912PL
Website www.qiagen.com
Telephone 31 77 3556600
No of Employees 5,654
Industry Medical Equipment
Ticker Symbol & Exchange QGEN (NYSE)
Revenue (2025) $2.1B 5.7% (2025 vs 2024)
EPS XYZ
Net Income (2025) XYZ 408.3% (2025 vs 2024)
Market Cap* $6.8B
Net Profit Margin (2025) XYZ 380.6% (2025 vs 2024)
* As of and is in US$
View Qiagen NV financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Learn more

Qiagen NV premium industry data and analytics

130+

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

80+

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

2

IT Services Contracts

Improve competitive bidding with insights into all publicly disclosed IT services contracts for Qiagen NV (including IT outsourcing, business process outsourcing, systems integration & consulting and more).

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Qiagen NV’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Services Brands
Sample Technologies: Lab Consulting CPT
Primary Sample Technology Consumables Preventive Maintenance/Inspection Service Qiagen
Secondary Sample Technology Consumables Operational Qualification QuantiFERON
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Qiagen NV portfolio and identify potential areas for collaboration Understand Qiagen NV portfolio and identify potential areas for collaboration Learn more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2025 Contracts/Agreements In November, the company entered into an agreement to acquire Parse Biosciences, a biotechnology company.
2025 New Products/Services In October, the company introduced the EZ2 DNA Investigator Sep&Prep Kit, a fully automated solution.
2025 New Products/Services In September, the company introduced QIAstat‑Dx Rise, a version of the QIAstat-Dx automated syndromic testing system.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Learn more
Image for loader

Competitor Comparison

Key Parameters Qiagen NV Thermo Fisher Scientific Inc 2invest AG MilliporeSigma Promega Corp
Headquarters Netherlands United States of America Germany United States of America United States of America
City Venlo Waltham Heidelberg Burlington Madison
State/Province - Massachusetts Baden-Wurttemberg Massachusetts Wisconsin
No. of Employees 5,654 125,000 3 9,000 2,200
Entity Type Public Public Public Private Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Learn more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Learn more
Executives
Name Position Board Since Age
Stephen H. Rusckowski Chairman Executive Board 2025 69
Thierry Bernard Chief Executive Officer; Managing Director Senior Management 2020 62
Jean-Pascal Viola Head - Corporate Strategy & Business Development; Senior Vice President Senior Management 2022 -
Antonio Santos Head - Global Operations; Senior Vice President Senior Management 2022 -
Stephany Foster Head - Human Resources; Senior Vice President Senior Management 2019 -
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Qiagen NV key executives to enhance your sales strategy Gain insight into Qiagen NV key executives to enhance your sales strategy Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?